ERBB2 and triple-negative breast carcinoma: However, this tendency was not shown in the HR-negative HER2-negative subgroup (i.e. triple-negative breast cancer, TNBC) (All the P values were more than 0.05 in Jonckheere-Terpstra test, Fig. 3c).